Valneva SE announced that at the Extraordinary General Meeting (EGM) held on December 20, 2023 Valneva?s former Supervisory Board member Anne-Marie Graffin was elected as Chair of the Company?s new Board of Directors. Ms. Graffin is Vice Chair of Nanobiotix?s Supervisory Board, member of the Sartorius Stedim Biotech Board of Directors and member of Vetoquinol S. A Board of Directors. She has over 20 years of experience in life sciences and was an Executive Committee member at Sanofi Pasteur MSD.

Thomas Lingelbach will also serve on the Company?s new Board of Directors. Other members appointed to the Board of Directors included members of the former Supervisory Board: James Sulat, Dr. Kathrin Jansen, Bpifrance Participations (represented by Maïlys Ferrère) and James Connolly. As previously announced, Valneva also established an Executive Committee which will be comprised of members of the former Management Board including Thomas Lingelbach (Chief Executive Officer), Peter Bühler (Chief Financial Officer), Franck Grimaud (Chief Business Officer), Dr. Juan Carlos Jaramillo (Chief Medical Officer), Dipal Patel (Chief Commercial Officer), Frederic Jacotot (General Counsel), as well as Vincent Dequenne (Chief Operating Officer).

The Company plans to add a Chief People Officer and a Chief Scientific Officer to its Executive Committee in due course.